I agree that this site is using cookies. You can find further informations here.
X
Andrew T. Kuykendall
187  results:
Search for persons X
?
1

Proposals for Revised International Working Group-European ..:

Tefferi, Ayalew ; Barosi, Giovanni ; Passamonti, Francesco...
Blood Journal.  , 2024
Link: https://doi.org/10.1182/..
 
?
2

Interferons in the treatment of myeloproliferative neoplasm:

Vachhani, Pankit ; Mascarenhas, John ; Bose, Prithviraj...
Therapeutic Advances in Hematology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
3

SHP2 inhibition displays efficacy as a monotherapy and in c..:

Pandey, Garima ; Mazzacurati, Lucia ; Rowsell, Tegan M....
American Journal of Hematology.  99 (2024)  6 - p. 1040-1055 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Contemporary Challenges in Polycythemia Vera Management Fro..:

Kuykendall, Andrew T. ; Fine, Jennifer T. ; Kremyanskaya, Marina
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  8 - p. 512-522 , 2024
Link: https://doi.org/10.1016/..
 
?
5

MDS-266 A Comprehensive Assessment of the Molecular Interna..:

Aguirre, Luis E. ; Al Ali, Najla ; Sallman, David A....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S359-S360 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Treatment of hydroxyurea-resistant/intolerant polycythemia ..:

Kuykendall, Andrew T.
Annals of Hematology.  102 (2023)  5 - p. 985-993 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Momelotinib versus danazol in symptomatic patients with ana..:

Verstovsek, Srdan ; Gerds, Aaron T ; Vannucchi, Alessandro M...
The Lancet.  401 (2023)  10373 - p. 269-280 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Phase I Trial of CD8-Depleted Human Leukocyte Antigen (HLA)..:

Elmariah, Hany ; Kim, Jongphil ; Reid, Kayla...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S204-S205 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Young patients with myelofibrosis have distinct clinicomole..:

Horvat, Nathan P. ; Abdallah, Enas F. ; Xie, Zhuoer...
Annals of Hematology.  , 2023
Link: https://doi.org/10.1007/..
 
?
10

Correction to: Treatment of hydroxyurea-resistant/intoleran..:

Kuykendall, Andrew T.
Annals of Hematology.  102 (2023)  7 - p. 1967-1967 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Clinical characteristics and outcomes of EZH2-mutant myelod..:

Ball, Somedeb ; Aguirre, Luis E. ; Jain, Akriti G....
Leukemia Research.  124 (2023)  - p. 106999 , 2023
Link: https://doi.org/10.1016/..
 
?
12

POSTER: MDS-266 A Comprehensive Assessment of the Molecular..:

Aguirre, Luis E. ; Al Ali, Najla ; Sallman, David A....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S181 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 ..:

Patel, Manish R. ; Donnellan, William ; Byrne, Michael...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  9 - p. 674-686 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo +..:

Harrison, Claire N ; Gupta, Vikas K ; Gerds, Aaron T...
Future Oncology.  18 (2022)  27 - p. 2987-2997 , 2022
Link: https://doi.org/10.2217/..
 
?
15

Hypomethylating agent and venetoclax in patients with chron..:

Ball, Somedeb ; Jain, Akriti G. ; Aguirre, Luis E....
American Journal of Hematology.  97 (2022)  5 - p. , 2022
Link: https://doi.org/10.1002/..
 
1-15